• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 6-K filed by Check-Cap Ltd.

    1/23/26 8:35:13 AM ET
    $MBAI
    Medical Electronics
    Health Care
    Get the next $MBAI alert in real time by email
    6-K 1 ea0273867-6k_check.htm REPORT OF FOREIGN PRIVATE ISSUER

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    Form 6-K

     

    REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16

    UNDER THE SECURITIES EXCHANGE ACT OF 1934

     

    For the month of January 2026

     

    Commission File Number: 001-36848

     

    Check-Cap Ltd.

    (Exact Name of Registrant as Specified in Charter)

     

    Abba Hushi Avenue

    P.O. Box 1271

    Isfiya, 30090 Mount Carmel, Israel

    (Address of principal executive offices)

     

    Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

     

    Form 20-F ☒ Form 40-F ☐

     

     

     

     

     

     

    This Form 6-K is being incorporated by reference into Check-Cap Ltd.’s Registration Statements on Form F-3 (File No. 333-262401) and Form S-8 (File No. 333-203384, 333-226490 and 333-259666) filed with the Securities and Exchange Commission, to be a part thereof from the date on which this Report is submitted, to the extent not superseded by documents or reports subsequently filed or furnished.

     

    Nasdaq Compliance

     

    As previously disclosed, on September 3, 2025, Check-Cap Ltd. (the “Company”) received a deficiency letter from the Nasdaq Listing Qualifications Department notifying the Company that it is not in compliance with Nasdaq Listing Rule 5550(b)(1), which requires the Company maintain a minimum of $2,500,000 in stockholders’ equity (the “Equity Rule”).

     

    As disclosed in the Company’s Annual Report on Form 20-F filed with the Securities and Exchange Commission (“SEC”) on August 27, 2025, the Company fully impaired its loan receivable from Apollo Technology Capital Corporation (“Apollo”), formerly known as Nobul AI Corp., based on conditions existing as of December 31, 2024. During the six months ended June 30, 2025, new information regarding Apollo’s financial condition became available, including management’s valuation analysis in September 2025. Accordingly, the Company reinstated the recoverable portion of the loan receivable from Apollo in connection with its preparation of the financial statements for the six months ended June 30, 2025. Based on its consolidated unaudited financial statements as of and for the six months ended June 30, 2025 furnished with the SEC on December 30, 2025, the Company’s stockholders’ equity exceeded $2,500,000. As a result of reinstating the recoverable portion of the loan receivable from Apollo, the Company’s stockholders’ equity exceeds $2,500,000 as of the date of this filing, and, accordingly, the Company believes it is in compliance with the Equity Rule as of the date hereof.

     

    Nasdaq will continue to monitor the Company’s ongoing compliance with the Equity Rule. If at the time of its next periodic report the Company does not evidence compliance with the Equity Rule or other Nasdaq listing rules, it may be subject to delisting. The Company anticipates being in compliance with the Equity Rule at the time of the filing of its next periodic report.

     

    1

     

     

    SIGNATURE

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

     

      CHECK-CAP LTD.
       
      (Registrant)
         
    Date: January 23, 2026 By: /s/ David Lontini
      Name:  David Lontini
      Title: Interim Chief Executive Officer

     

    2

     

    Get the next $MBAI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $MBAI

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $MBAI
    SEC Filings

    View All

    SEC Form F-1 filed by Check-Cap Ltd.

    F-1 - Check-Cap Ltd (0001610590) (Filer)

    1/30/26 5:28:42 PM ET
    $MBAI
    Medical Electronics
    Health Care

    SEC Form 6-K filed by Check-Cap Ltd.

    6-K - Check-Cap Ltd (0001610590) (Filer)

    1/30/26 5:00:20 PM ET
    $MBAI
    Medical Electronics
    Health Care

    SEC Form 6-K filed by Check-Cap Ltd.

    6-K - Check-Cap Ltd (0001610590) (Filer)

    1/26/26 8:35:18 AM ET
    $MBAI
    Medical Electronics
    Health Care

    $MBAI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Check-Cap Clears Key Nasdaq Requirement, Advancing MBody AI Merger Toward Completion

    ISFIYA, Israel, Jan. 26, 2026 (GLOBE NEWSWIRE) -- Check-Cap Ltd. (NASDAQ:MBAI) ("Check-Cap" or the "Company") today announced that it has received written confirmation from the Nasdaq Listing Qualifications Department that the Company has regained compliance with Nasdaq's minimum shareholders' equity requirements pursuant to Nasdaq Listing Rule 5550(b). This confirmation clears a key regulatory requirement and represents a significant positive milestone as Check-Cap advances toward completion of its previously announced, shareholder-approved merger with MBody AI. The merger is expected to transform Check-Cap into a publicly traded leader in embodied artificial intelligence, subject to c

    1/26/26 9:50:00 AM ET
    $MBAI
    Medical Electronics
    Health Care